Intravenous heparin therapy in acute ischaemic cerebral infarct: Contra;Intravenöse heparintherapie beim akuten ischämischen hirninfarkt - Contra

Aktuelle Neurologie

Volumn 28, Issue 3, 2001, Pages 122-127

  Hamann, G F ^a   Diener, H C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; BLOOD CLOT LYSIS; BRAIN INFARCTION; HUMAN; ISCHEMIA; NEUROPROTECTION; PROPHYLAXIS; REVIEW; TREATMENT INDICATION;

EID: 0035040581     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-12521     Document Type: Review

References (60)

1. Akuttherapie des schlaganfalls
2. Antithrombotic and thrombolytic therapy for ischemic stroke
3. Intravenous heparin for acute stroke: What can we learn from the megatrials?
4. Use of antithrombotic drugs in the treatment of acute ischemic stroke: A survey of nuerologists in practice in the United States
5. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
6. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: A meta-analysis of randomized controlled trials
7. Niedermolekulares heparin: Eine soforttherapie des schlaganfalls? Eine diskussion der studie yon Kay et al: Low molecular weight heparin for treatment of acute ischemic stroke
8. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke
9. Hemorrhage and anticoagulation after nonseptic embolic brain infarction
10. Usefulness of heparin in initial management of patients with recent transient ischemic attacks
11. Recurrent embolic cerebral infarction and anticoagulation
12. Heparintherapie bei embolischen, zerebralen insulten. Eine retrospektive untersuchung
13. Risk of early anticoagulation in patients with small deep infarcts possibly caused by cardiogenic emboli
14. Evaluation of anticoagulants in patients with cerebral infarction with slight to moderate neurological deficit
15. Treatment of acute ischemic stroke. Open trial with continuous intravenous heparinization
16. Low-molecular-weight heparin for the treatment of acute ischemic stroke
17. Heparin should not be used presently for acute ischaemic stroke
18. One year after CAPRIE, IST and ESPS 2. Any changes in concepts?
19. Fraxiparine in ischaemic stroke
20. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: A randomized controlled trial
21. ABC of arterial and venous disease. Acute stroke
22. Anticoagulants for acute ischaemic stroke. CD000024
23. Heparin in acute ischaemic stroke. The T wave is negative and it's time to stop
24. Immediate anticoagulation of embolic stroke: Brain hemorrhage and management options
25. Immediate anticoagulation of embolic stroke: A randomized trial
26. Is there still a role for intravenous heparin in acute stroke? No
27. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke
28. CAST: Randomised placebo-controlled trial of early aspirin use in 20000 patients with acute ischaemic stroke
29. Is there still a role for intravenous heparin in acute stroke? Yes
30. Risk factors for early recurrence after ischemic stroke: The role of stroke syndrome and subtype
31. Intravenous heparin in acute stroke
32. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: A double-blind randomised study
33. Safety of anticoagulation after hemorrhagic infarction
34. Intracerebral hemorrhage after experimental embolic infarction. Anticoagulation
35. Intracerebral hemorrhage in stroke patients anticoagulated with heparin
36. Cardiogenic versus atherothrombotic embolic stroke - In which cases is heparin therapy useful?
37. Heparin and oral anticoagulants in the treatment of brain ischemia
38. Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study
39. Heparin-induced thrombo-cytopenia
40. Heparin-inducted thrombocytopenia in patients with cerebrovascular ischemic disease
41. Heparin-induced thrombocytopenia with multiple cerebral infarctions simulating thrombotic thrombocytopenic purpura. A case report
42. Posttreatment with low molecular weight heparin reduces brain edema and infarct volume in rats subjected to thrombotic middle cerebral artery occlusion
43. Heparin in acute stroke with atrial fibrillation: Clinical relevance of very early treatment
44. Molecular biology of blood-brain barrier ontogenesis and function
45. Frühe antikoagulation beim akuten ischämischen hirninfarkt
46. Dissection of the cervical internal carotid artery. The role of Doppler/Duplex studies and conservative management
47. Spontaneous carotid dissection with acute stroke
48. Diagnosis, treatment, and outcome of blunt carotid arterial injuries
49. Zerebrale ischämien als erst-manifestation neoplastischer veränderungen niedriger malignitat. 2 Fallberichte und übersicht über die literatur
50. Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability?
51. Impact of transesophageal echocardiography on the anticoagulation management of patients admitted with focal cerebral ischemia
52. Antikoagulation beim akuten schlaganfall. Nutzen, risiken, therapieversager
53. Frühe antikoagulation beim akuten ischämischen hirninfarkt
54. Antithrombotische therapie nach zerebraler ischämie
55. Failure of heparin to prevent progression in progressing ischemic infarction
56. Heparin for lacunar stroke in progression
57. Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack. CD000248
58. Early anticoagulation after large cerebral embolic infarction: A safety study
59. Treatment in a combined acute and rehabilitation stroke unit: Which aspects are most important?